RosVivo Therapeutics, Inc. — Form D

RosVivo Therapeutics, Inc. of RENO, NV, a company, filed a Form D exempt-offering notice with the SEC on 2021-06-08. The offering totals $5.5M, of which $5.5M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2021-06-08
• Form: D
• Accession: 0001866386-21-000002
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $5.5M
• Amount sold: $5.5M
• Minimum investment: $5.5M
• Investors: 1
• Date of first sale: 2021-05-26
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-402098

Issuer

• Name: RosVivo Therapeutics, Inc.
• CIK: 0001866386
• Entity type: Corporation
• Jurisdiction: NEVADA
• Incorporated: 2021
• Address: APPLIED RESEARCH FACILITY, ROOM 320, RENO, NV, 89557
• Phone: 775-409-6007

Officers, directors & promoters (2)

More

• CIK 1866386 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search